Centiva Capital »

Edgewise Therapeutics shares owned by Centiva Capital

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Centiva Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $310k 13k 24.82

More positions owned by Centiva Capital

Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Put Option (TSLA)
Meta Platforms Cl A Call Option (META)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Alibaba Group Hldg Sponsored Ads Put Option (BABA)
Apple Call Option (AAPL)
Pdd Holdings Sponsored Ads Put Option (PDD)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Regeneron Pharmaceuticals Call Option (REGN)
Eli Lilly & Co. Put Option (LLY)
Kraneshares Trust Csi Chi Internet Call Option (KWEB)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Honeywell International (HON)
Jd.com Spon Ads Cl A (JD)

View all positions for Centiva Capital

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
Baker Bros. Advisors
BlackRock
Paradigm Biocapital Advisors
Novo A/S
Braidwell
Henderson Group
Vanguard Group
Siren
Perceptive Advisors
Cormorant Asset Management
Driehaus Capital Management
UBS Group
Geode Capital Management

View all funds holding Edgewise Therapeutics